Similar articles

• HIV treatment series. Part 4 of 4. Decisions, decisions--starting or switching anti-HIV therapy.

  McGuire S. McGuire S. Posit Aware. 2003 May-Jun;14(3):31-6. Posit Aware. 2003. PMID: 12866490 No abstract available.
• US revises adult/adolescent antiretroviral therapy guidelines.

  [No authors listed] [No authors listed] IAPAC Mon. 2003 Aug;9(8):181. IAPAC Mon. 2003. PMID: 14672071 No abstract available.
• Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.

  Grant PM, Zolopa AR. Grant PM, et al. Curr Opin Investig Drugs. 2010 Aug;11(8):901-10. Curr Opin Investig Drugs. 2010. PMID: 20721832 Review.
• [Highly active initial therapy without resistance development. Even after 6 years still effective HIV therapy].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:54-5. MMW Fortschr Med. 2005. PMID: 16385876 German. No abstract available.
• HIV therapeutics: points from the recent literature.

  Laurence J. Laurence J. AIDS Read. 2003 Jul;13(7):305, 307. AIDS Read. 2003. PMID: 12889448 Review. No abstract available.